Tricuspid annular plane systolic excursion (TAPSE) in pediatric pulmonary hypertension: Integrating right ventricular

Martin Koestenberger1, Alexander Avian2, Massimiliano Cantinotti3

  • 1Division of Pediatric Cardiology, Department of Pediatrics, Medical University Graz, Austria.

Insights

New echocardiographic ratios improve assessment of right ventricular function in pediatric pulmonary hypertension. These multiparametric indices, unlike single measures, better distinguish functional classes in children with PH.

Area of Science:

  • Pediatric Cardiology
  • Echocardiography
  • Pulmonary Hypertension

Background:

  • Tricuspid annular plane systolic excursion (TAPSE) is a key echocardiographic measure of right ventricular (RV) systolic function in pediatric pulmonary hypertension (PH).
  • Current research emphasizes multi-parametric approaches for RV function assessment in children with PH.

Purpose of the Study:

  • To investigate the utility of RV ejection efficiency (RVEe; TAPSE/indexed pulmonary vascular resistance) and the TAPSE/pulmonary systolic arterial pressure (PASP) ratio.
  • To assess the association of these novel indices with NYHA functional class (FC) and modified ROSS score in pediatric PH.

Main Methods:

  • Retrospective analysis of 42 children diagnosed with PH.
  • Calculation of RVEe (TAPSE/PVRi) and TAPSE/PASP ratio.
  • Correlation of these indices with NYHA FC and modified ROSS score.

Main Results:

  • Both RVEe and the TAPSE/PASP ratio showed an inverse relationship with NYHA FC and modified ROSS score.
  • Multiparametric variables (RVEe, TAPSE/PASP) demonstrated more pronounced differences between functional classes compared to TAPSE alone.
  • These ratios effectively distinguish between different NYHA FC/modified ROSS score groups.

Conclusions:

  • Multiparametric echocardiographic indices like RVEe and TAPSE/PASP ratio offer improved assessment of RV function in pediatric PH.
  • These ratios are more effective than TAPSE alone in differentiating functional severity in children with PH.
  • A multiparametric approach enhances the clinical utility of echocardiography for evaluating pediatric pulmonary hypertension.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
646
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
604
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
468
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
508
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
622
Work Done Over an Inclined Plane01:11

Work Done Over an Inclined Plane

The center-of-mass framework helps to easily describe the work done on rigid bodies. Since the internal forces in a rigid body do no work, they can be ignored, and the external forces can be considered in the work-energy theorem.
The work done by gravity to move a rigid body, or the work done by an opposing force to move a rigid body against gravity, can be calculated using the center-of-mass framework. It is the line integral of the force of gravity over the path, considered positive if...
4.0K